These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 38634649)

  • 1. Epitranscriptomic Regulations in the Heart.
    Benak D; Kolar F; Hlavackova M
    Physiol Res; 2024 Apr; 73(Suppl 1):S185-S198. PubMed ID: 38634649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases.
    Teng PC; Liang Y; Yarmishyn AA; Hsiao YJ; Lin TY; Lin TW; Teng YC; Yang YP; Wang ML; Chien CS; Luo YH; Chen YM; Hsu PK; Chiou SH; Chien Y
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unravelling the impact of RNA methylation genetic and epigenetic machinery in the treatment of cardiomyopathy.
    Liu L; Yu L; Wang Y; Zhou L; Liu Y; Pan X; Huang J
    Pharmacol Res; 2024 Sep; 207():107305. PubMed ID: 39002868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA modification m
    Benak D; Kolar F; Zhang L; Devaux Y; Hlavackova M
    Epigenetics; 2023 Dec; 18(1):2218771. PubMed ID: 37331009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel insight into the regulatory roles of diverse RNA modifications: Re-defining the bridge between transcription and translation.
    Shi H; Chai P; Jia R; Fan X
    Mol Cancer; 2020 Apr; 19(1):78. PubMed ID: 32303268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequencing methods and functional decoding of mRNA modifications.
    Li K; Peng J; Yi C
    Fundam Res; 2023 Sep; 3(5):738-748. PubMed ID: 38933299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the Epitranscriptomic Signatures in Cell Fate Determination and Development.
    Haran V; Lenka N
    Stem Cell Rev Rep; 2019 Aug; 15(4):474-496. PubMed ID: 31123982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitranscriptomic Modifications Modulate Normal and Pathological Functions in CNS.
    Chokkalla AK; Mehta SL; Vemuganti R
    Transl Stroke Res; 2022 Feb; 13(1):1-11. PubMed ID: 34224107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy.
    Liu WW; Zheng SQ; Li T; Fei YF; Wang C; Zhang S; Wang F; Jiang GM; Wang H
    Signal Transduct Target Ther; 2024 Mar; 9(1):70. PubMed ID: 38531882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitranscriptomics and cervical cancer: the emerging role of m
    Modi AD; Zahid H; Southerland AC; Modi DM
    Expert Rev Mol Med; 2024 Oct; 26():e20. PubMed ID: 39377535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitranscriptomics as a New Layer of Regulation of Gene Expression in Skeletal Muscle: Known Functions and Future Perspectives.
    Imbriano C; Moresi V; Belluti S; Renzini A; Cavioli G; Maretti E; Molinari S
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplays of different types of epitranscriptomic mRNA modifications.
    Rengaraj P; Obrdlík A; Vukić D; Varadarajan NM; Keegan LP; Vaňáčová Š; O'Connell MA
    RNA Biol; 2021 Oct; 18(sup1):19-30. PubMed ID: 34424827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress in epigenetic modification of mRNA and the function of m6A modification].
    Gan H; Hong L; Yang F; Liu D; Jin L; Zheng Q
    Sheng Wu Gong Cheng Xue Bao; 2019 May; 35(5):775-783. PubMed ID: 31222996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of m
    Benak D; Benakova S; Plecita-Hlavata L; Hlavackova M
    Front Endocrinol (Lausanne); 2023; 14():1223583. PubMed ID: 37484960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Repertoire of RNA Modifications Orchestrates a Plethora of Cellular Responses.
    Adamopoulos PG; Athanasopoulou K; Daneva GN; Scorilas A
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. m6A epitranscriptomic and epigenetic crosstalk in liver fibrosis: Special emphasis on DNA methylation and non-coding RNAs.
    Dong QQ; Yang Y; Tao H; Lu C; Yang JJ
    Cell Signal; 2024 Oct; 122():111302. PubMed ID: 39025344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of mRNA methylation in normal and pathological behavior.
    Engel M; Chen A
    Genes Brain Behav; 2018 Mar; 17(3):e12428. PubMed ID: 29027751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Roles of N6-Methyladenosine (m6A) Epitranscriptomics in Toxicology.
    Malovic E; Ealy A; Kanthasamy A; Kanthasamy AG
    Toxicol Sci; 2021 Apr; 181(1):13-22. PubMed ID: 33616673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translational Regulation by eIFs and RNA Modifications in Cancer.
    Zhang L; Zhang Y; Zhang S; Qiu L; Zhang Y; Zhou Y; Han J; Xie J
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular structure and biological functions of RNA methylation, with special emphasis on the roles of RNA methylation in autoimmune diseases.
    Zhou W; Wang X; Chang J; Cheng C; Miao C
    Crit Rev Clin Lab Sci; 2022 May; 59(3):203-218. PubMed ID: 34775884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.